Firefly Neuroscience (AIFF) Director Menawat Swarup Receives Award

What Happened Menawat Arun Swarup, a director of Firefly Neuroscience, was granted 126,050 deferred stock units (DSUs) on September 25, 2026. The Form 4 records this as a derivative acquisition at $0.00 per unit (no cash exchanged). Each DSU represents a contingent right to receive one share of the issuer's common stock and the units vest quarterly over a 12‑month period.

Key Details

• Transaction date: 2026-09-25 (Grant/Award; transaction code A)
• Form 4 filed: 2026-09-29 (appears to be filed within the normal SEC 2-business-day window)
• Quantity: 126,050 DSUs; reported price: $0.00 per unit (derivative award)
• Shares owned after transaction: Not specified in this Form 4 filing
• Footnote: DSUs were granted under the Issuer’s 2024 Long-Term Incentive Plan and vest quarterly over a 12‑month period; each DSU is a contingent right to one common share.
• No immediate sale or market purchase occurred—this is a compensation award, not a purchase.

Context DSUs are deferred compensation: they generally convert to actual shares (or cash/share equivalents) only as they vest, so they are not immediate open‑market purchases or sales. Awards like this are commonly used for director compensation and retention; they are factual disclosures of grant activity and do not by themselves indicate the insider is buying or selling shares in the open market.